Rocket Doctor AI Reports Strong 2025 Results, Validating Physician-Led Model with Key U.S. Payer Contracts and AI Innovation

Continued organic quarter over quarter revenue growth with growth of over 30% from Q3 to Q4 2025 (from $529,123 in Q3 2025 to $697,340 for Q4 2025) Earnings per share for Q4, 2025: ($0. 10) per share. Annual Revenues of $1. 739 million in FY2025 Announced signed in-network contracts and credentialing with several major U.